Cargando…

28. The Paradox of an Integrated MAT OPAT Program

BACKGROUND: Patients with substance use disorders (SUD), specifically opioid use disorder (OUD) and injection drug use (IDU) utilize healthcare resources for prolonged inpatient treatment of serious infections stemming from their addictions. For a variety of reasons, physicians treating these patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Eckardt, Paula, Reed, Jessica, Vicencio, Claudia P, Augsten, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643730/
http://dx.doi.org/10.1093/ofid/ofab466.230
_version_ 1784609919292407808
author Eckardt, Paula
Reed, Jessica
Vicencio, Claudia P
Augsten, Alberto
author_facet Eckardt, Paula
Reed, Jessica
Vicencio, Claudia P
Augsten, Alberto
author_sort Eckardt, Paula
collection PubMed
description BACKGROUND: Patients with substance use disorders (SUD), specifically opioid use disorder (OUD) and injection drug use (IDU) utilize healthcare resources for prolonged inpatient treatment of serious infections stemming from their addictions. For a variety of reasons, physicians treating these patients refuse to send these patients home to receive outpatient parenteral antimicrobial therapy (OPAT), and instead keep the patient in the hospital for several weeks or longer to complete treatment for the injection-related infections. Patients who do not have history of IDU are sent home with a PICC line to receive OPAT once they are no longer acutely ill and therefore no longer meet criteria to remain inpatient, which is the established standard of care. Patients with OUD and IDU are not allowed the same standard of care, and furthermore do not receive adequate, if any, therapy for their primary problem and reason for their serious infection – the addiction. Flow chart of the MAT-OPAT process [Image: see text] METHODS: Medication-assisted treatment (MAT) with buprenorphine-naloxone has been approved for treating adults with opioid use disorder as part of a comprehensive treatment program that also includes counseling and behavioral therapy. Until now in our healthcare system there has been no comprehensive and integrated program to safely discharge patients with OUD and IDU to receive OPAT via a PICC line, while simultaneously treating their addiction. We describe the implementation of a MAT-OPAT program. Please refer to the chart included. RESULTS: We present a successful case of a 36-year-old male with a history of endocarditis associated with IV drug use and the intervention of the Healthcare System to link the patient to appropriate Infectious disease, behavioral health and medication adherence treatment for opioid abuse. The patient completed the IV antibiotic therapy and remained enrolled in the behavioral health program with a successful outcome. CONCLUSION: MAT-OPAT implementation in large healthcare system with continuous outpatient support that includes Infectious Disease services, behavioral health and drug abuse rehabilitation therapy can be a successful strategy to minimize readmisión, cost and complications in patients with history of IV drug use and infections that require prolonged intravenous antibiotic therapy. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-8643730
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86437302021-12-06 28. The Paradox of an Integrated MAT OPAT Program Eckardt, Paula Reed, Jessica Vicencio, Claudia P Augsten, Alberto Open Forum Infect Dis Poster Abstracts BACKGROUND: Patients with substance use disorders (SUD), specifically opioid use disorder (OUD) and injection drug use (IDU) utilize healthcare resources for prolonged inpatient treatment of serious infections stemming from their addictions. For a variety of reasons, physicians treating these patients refuse to send these patients home to receive outpatient parenteral antimicrobial therapy (OPAT), and instead keep the patient in the hospital for several weeks or longer to complete treatment for the injection-related infections. Patients who do not have history of IDU are sent home with a PICC line to receive OPAT once they are no longer acutely ill and therefore no longer meet criteria to remain inpatient, which is the established standard of care. Patients with OUD and IDU are not allowed the same standard of care, and furthermore do not receive adequate, if any, therapy for their primary problem and reason for their serious infection – the addiction. Flow chart of the MAT-OPAT process [Image: see text] METHODS: Medication-assisted treatment (MAT) with buprenorphine-naloxone has been approved for treating adults with opioid use disorder as part of a comprehensive treatment program that also includes counseling and behavioral therapy. Until now in our healthcare system there has been no comprehensive and integrated program to safely discharge patients with OUD and IDU to receive OPAT via a PICC line, while simultaneously treating their addiction. We describe the implementation of a MAT-OPAT program. Please refer to the chart included. RESULTS: We present a successful case of a 36-year-old male with a history of endocarditis associated with IV drug use and the intervention of the Healthcare System to link the patient to appropriate Infectious disease, behavioral health and medication adherence treatment for opioid abuse. The patient completed the IV antibiotic therapy and remained enrolled in the behavioral health program with a successful outcome. CONCLUSION: MAT-OPAT implementation in large healthcare system with continuous outpatient support that includes Infectious Disease services, behavioral health and drug abuse rehabilitation therapy can be a successful strategy to minimize readmisión, cost and complications in patients with history of IV drug use and infections that require prolonged intravenous antibiotic therapy. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8643730/ http://dx.doi.org/10.1093/ofid/ofab466.230 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Eckardt, Paula
Reed, Jessica
Vicencio, Claudia P
Augsten, Alberto
28. The Paradox of an Integrated MAT OPAT Program
title 28. The Paradox of an Integrated MAT OPAT Program
title_full 28. The Paradox of an Integrated MAT OPAT Program
title_fullStr 28. The Paradox of an Integrated MAT OPAT Program
title_full_unstemmed 28. The Paradox of an Integrated MAT OPAT Program
title_short 28. The Paradox of an Integrated MAT OPAT Program
title_sort 28. the paradox of an integrated mat opat program
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643730/
http://dx.doi.org/10.1093/ofid/ofab466.230
work_keys_str_mv AT eckardtpaula 28theparadoxofanintegratedmatopatprogram
AT reedjessica 28theparadoxofanintegratedmatopatprogram
AT vicencioclaudiap 28theparadoxofanintegratedmatopatprogram
AT augstenalberto 28theparadoxofanintegratedmatopatprogram